Results from a global trial across 148 sites in 23 countries, showing a 30 per cent improvement in survival in patients with acute myeloid leukemia (AML), significantly improving survival in older patients, over the age of 55, with the disease. AML is the most acute blood cancer in adults and its incidence increases with age, with a poor prognosis.
from Latest Science News -- ScienceDaily https://ift.tt/3rBrttM
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment